标题
Hereditary breast cancer: syndromes, tumour pathology and molecular testing
作者
关键词
-
出版物
HISTOPATHOLOGY
Volume 82, Issue 1, Pages 70-82
出版商
Wiley
发表日期
2022-12-05
DOI
10.1111/his.14808
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion
- (2022) Debyani Chakravarty et al. JOURNAL OF CLINICAL ONCOLOGY
- Homologous Recombination Deficiency: Concepts, Definitions, and Assays
- (2022) Mark D Stewart et al. ONCOLOGIST
- Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
- (2022) et al. JAMA Oncology
- Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
- (2022) Benedetta Pellegrino et al. CANCER RESEARCH
- Cell cycle regulation: p53-p21-RB signaling
- (2022) Kurt Engeland CELL DEATH AND DIFFERENTIATION
- Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors
- (2022) Lola Paulet et al. EUROPEAN JOURNAL OF CANCER
- Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management
- (2022) Giovanni Corso JOURNAL OF SURGICAL ONCOLOGY
- Predictive biomarkers for molecularly targeted therapies and immunotherapies in breast cancer
- (2022) Mi Jeong Kwon ARCHIVES OF PHARMACAL RESEARCH
- A Population-Based Study of Genes Previously Implicated in Breast Cancer
- (2021) Chunling Hu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update
- (2021) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Testing in Breast Cancer
- (2021) Lulu Sun et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
- (2021) Andrew N.J. Tutt et al. NEW ENGLAND JOURNAL OF MEDICINE
- The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities
- (2021) Stefania Stella et al. Translational Oncology
- Penetrance of male breast cancer susceptibility genes: a systematic review
- (2021) Reem S. Chamseddine et al. BREAST CANCER RESEARCH AND TREATMENT
- CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
- (2021) Elio Adib et al. BRITISH JOURNAL OF CANCER
- Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk
- (2021) Lauren A. Gamble et al. JAMA Surgery
- Molecular Pathology of Lynch Syndrome
- (2020) G Cerretelli et al. JOURNAL OF PATHOLOGY
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
- (2020) Neha Chopra et al. Nature Communications
- TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of polygenic risk and susceptibility genes in breast cancer over the course of life
- (2020) Nina Mars et al. Nature Communications
- Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer
- (2019) Camilla Wendt et al. ACTA ONCOLOGICA
- Novel germline STK11 variants and breast cancer phenotype identified in an Indian cohort of Peutz–Jeghers syndrome
- (2019) Anuja Lipsa et al. HUMAN MOLECULAR GENETICS
- Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- (2019) R Condorelli et al. ANNALS OF ONCOLOGY
- Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
- (2019) K Nones et al. ANNALS OF ONCOLOGY
- Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria
- (2019) Rosa M Xicola et al. JOURNAL OF MEDICAL GENETICS
- Pathology of BRCA1- and BRCA2- associated breast cancers: Known and less known connections
- (2019) Elena Fountzilas et al. Clinical Breast Cancer
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
- (2019) Xin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark
- (2018) Shan Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Revisiting tumor patterns and penetrance in germline TP53 mutation carriers
- (2018) Amina Amadou et al. CURRENT OPINION IN ONCOLOGY
- MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer
- (2018) Maegan E Roberts et al. GENETICS IN MEDICINE
- Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect
- (2018) Giovanni Corso et al. JOURNAL OF MEDICAL GENETICS
- The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
- (2018) Britta Weigelt et al. JNCI-Journal of the National Cancer Institute
- Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations
- (2018) Giovanni Corso et al. Personalized Medicine
- The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
- (2018) Britta Weigelt et al. JNCI-Journal of the National Cancer Institute
- Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers
- (2018) X Chen et al. ANNALS OF ONCOLOGY
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
- (2018) Haixia Chen et al. Frontiers in Pharmacology
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
- (2018) Nasim Mavaddat et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
- (2018) Peter D. Beitsch et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtypes in BRCA-mutated breast cancer
- (2018) Ida Marie H. Sønderstrup et al. HUMAN PATHOLOGY
- Clinical Implications for Germline PTEN Spectrum Disorders
- (2017) Joanne Ngeow et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer
- (2017) Xia Wang et al. GENES CHROMOSOMES & CANCER
- Cancer risk and survival inpath_MMRcarriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
- (2017) Pål Møller et al. GUT
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry
- (2017) Mira Goldberg et al. JOURNAL OF MEDICAL GENETICS
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B Kuchenbaecker et al. JNCI-Journal of the National Cancer Institute
- Association analysis identifies 65 new breast cancer risk loci
- (2017) Kyriaki Michailidou et al. NATURE
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
- (2017) Roger L Milne et al. NATURE GENETICS
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast cancer metastasizing to the stomach mimicking primary gastric cancer: A case report
- (2017) Kwangil Yim et al. WORLD JOURNAL OF GASTROENTEROLOGY
- InheritedTP53Mutations and the Li–Fraumeni Syndrome
- (2017) Tanya Guha et al. Cold Spring Harbor Perspectives in Medicine
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B Kuchenbaecker et al. JNCI-Journal of the National Cancer Institute
- Neurofibromatosis type 1
- (2017) David H. Gutmann et al. Nature Reviews Disease Primers
- Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors
- (2016) Elina Uusitalo et al. BRITISH JOURNAL OF CANCER
- Risks of first and subsequent cancers amongTP53mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort
- (2016) Phuong L. Mai et al. CANCER
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline
- (2016) N.J.H. van Os et al. CLINICAL GENETICS
- Penetrance ofATMGene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk
- (2016) Monica Marabelli et al. GENETIC EPIDEMIOLOGY
- Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
- (2016) Taru A. Muranen et al. GENETICS IN MEDICINE
- Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
- (2016) Pål Møller et al. GUT
- Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study
- (2016) Charlotte Näslund-Koch et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
- (2016) Elina Uusitalo et al. JOURNAL OF CLINICAL ONCOLOGY
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Genetics of breast cancer: a topic in evolution
- (2015) S. Shiovitz et al. ANNALS OF ONCOLOGY
- Breast cancer risk and clinical implications for germline PTEN mutation carriers
- (2015) Joanne Ngeow et al. BREAST CANCER RESEARCH AND TREATMENT
- Beyond BRCA: New hereditary breast cancer susceptibility genes
- (2015) P. Economopoulou et al. CANCER TREATMENT REVIEWS
- Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
- (2015) Pål Møller et al. GUT
- Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
- (2015) Gaëlle Bougeard et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Lynch syndrome caused byMLH1mutations is associated with an increased risk of breast cancer: a cohort study
- (2015) Elaine F Harkness et al. JOURNAL OF MEDICAL GENETICS
- Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
- (2015) Kyriaki Michailidou et al. NATURE GENETICS
- Hereditary Diffuse Gastric Cancer Syndrome
- (2015) Samantha Hansford et al. JAMA Oncology
- Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma
- (2015) Ondrej Havranek et al. PLoS One
- Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian
- (2014) Jacqueline Mersch et al. CANCER
- Li-Fraumeni syndrome: cancer risk assessment and clinical management
- (2014) Kate A. McBride et al. Nature Reviews Clinical Oncology
- Breast-Cancer Risk in Families with Mutations in PALB2
- (2014) Antonis C. Antoniou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
- (2014) Elinor Sawyer et al. PLoS Genetics
- Risk Factors for Breast Cancer for Women Aged 40 to 49 Years
- (2013) Heidi D. Nelson ANNALS OF INTERNAL MEDICINE
- Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
- (2013) M. Ambrose et al. BLOOD
- Tumour morphology predicts PALB2 germline mutation status
- (2013) Z L Teo et al. BRITISH JOURNAL OF CANCER
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer
- (2013) M. Janatova et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The complex genetic landscape of familial breast cancer
- (2013) Lorenzo Melchor et al. HUMAN GENETICS
- CDH1germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study
- (2013) Patrick R Benusiglio et al. JOURNAL OF MEDICAL GENETICS
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria
- (2013) R. Pilarski et al. JNCI-Journal of the National Cancer Institute
- Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
- (2012) Serena Masciari et al. BREAST CANCER RESEARCH AND TREATMENT
- The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
- (2012) J Iqbal et al. BRITISH JOURNAL OF CANCER
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- (2012) N. Mavaddat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
- (2012) M.-H. Tan et al. CLINICAL CANCER RESEARCH
- Colorectal and Other Cancer Risks for Carriers and Noncarriers From Families With a DNA Mismatch Repair Gene Mutation: A Prospective Cohort Study
- (2012) Aung Ko Win et al. JOURNAL OF CLINICAL ONCOLOGY
- CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer
- (2012) Maren Weischer et al. JOURNAL OF CLINICAL ONCOLOGY
- A Role for Common Genomic Variants in the Assessment of Familial Breast Cancer
- (2012) Sarah Sawyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Homologous recombination and its regulation
- (2012) L. Krejci et al. NUCLEIC ACIDS RESEARCH
- Early onset HER2-positive breast cancer is associated with germlineTP53mutations
- (2011) Amal Melhem-Bertrandt et al. CANCER
- Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
- (2011) S. Casadei et al. CANCER RESEARCH
- High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome
- (2011) M. G. F. van Lier et al. GUT
- Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
- (2011) Cezary Cybulski et al. JOURNAL OF CLINICAL ONCOLOGY
- Lynch Syndrome-Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry
- (2010) M. D. Walsh et al. CLINICAL CANCER RESEARCH
- Peutz-Jeghers syndrome: a systematic review and recommendations for management
- (2010) A. D. Beggs et al. GUT
- BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study
- (2010) Adriana J. Rijnsburger et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
- (2010) J. R. F. Wilson et al. JOURNAL OF MEDICAL GENETICS
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Pathology of hereditary breast cancer
- (2010) Leonard Da Silva et al. MODERN PATHOLOGY
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- Radio-induced malignancies after breast cancer post-operative radiotherapy in patients with Li- Fraumeni syndrome
- (2010) Steve Heymann et al. Radiation Oncology
- Subtypes of familial breast tumours revealed by expression and copy number profiling
- (2009) Nic Waddell et al. BREAST CANCER RESEARCH AND TREATMENT
- The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
- (2009) T. Heikkinen et al. CLINICAL CANCER RESEARCH
- PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
- (2009) Feng Zhang et al. CURRENT BIOLOGY
- Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response
- (2009) Travis H. Stracker et al. DNA REPAIR
- Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population
- (2009) Cecelia A Bellcross et al. GENETICS IN MEDICINE
- PTEN hamartoma tumor syndrome: An overview
- (2009) Judith A Hobert et al. GENETICS IN MEDICINE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- PALB2 is an integral component of the BRCA complex required for homologous recombination repair
- (2009) S. M. H. Sy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
- (2009) S. Jones et al. SCIENCE
- Targeted therapy for cancer using PARP inhibitors
- (2008) Christopher J Lord et al. CURRENT OPINION IN PHARMACOLOGY
- CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls
- (2008) Maren Weischer et al. JOURNAL OF CLINICAL ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- Cowden Syndrome: A Critical Review of the Clinical Literature
- (2008) Robert Pilarski Journal of Genetic Counseling
- The emerging landscape of breast cancer susceptibility
- (2007) Michael R Stratton et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now